Skip to main navigation

USA English

Brazil Português

Canada English Français

Japan Japanese

Blog
Patient Resources
Investors & Media
Careers
Contact

Our Purpose
Our Company
Our Medicines
Our Research

Blog
Patient Resources
Investors & Media
Careers
Contact

Event Details

Fourth Quarter 2022 Financial Results and Corporate Update

Feb 16, 2023 at 5:00 PM EST

Listen to Webcast

INVESTORS & MEDIA

Press Releases
Events & Presentations
Corporate Governance
SEC Filings
Stock Information
Analyst Coverage
Investor FAQ
Contact Us

SHAREHOLDER TOOLS

Print
Email Alerts
RSS Feeds

You are about to leave the Ultragenyx website.

Do you want to continue?

Ultragenyx is not responsible for the content or availability of third party sites.

Our Purpose
Our Company
Our Medicines
Our Research
Careers
Investors & Media

Our Other Websites

www.UltraRareAdvocacy.com
www.UltraCareSupport.com

Linkedin
Facebook

©2023 Ultragenyx Pharmaceutical Inc.. All rights reserved.

Privacy Policy
Cookie Policy